Results 281 to 290 of about 159,476 (341)
Abstract Background and objective The Current European Association of Urology guidelines do not provide recommendation for combination of regenerative therapies with standard therapies for erectile dysfunction. The aim of this study was to compare the efficacy of combined regenerative therapy with monotherapy for erectile dysfunction.
Alberto Quistini +12 more
wiley +1 more source
Efficacy of intradiscal autologous platelet-rich plasma injection in chronic lumbar disc prolapse: A quasi-experimental study. [PDF]
Mounisamy P +6 more
europepmc +1 more source
ABSTRACT Background Hyperpigmentation disorders, including melasma and post‐inflammatory hyperpigmentation (PIH), are common dermatologic conditions associated with significant cosmetic and psychological burden. Tranexamic acid (TXA), an antifibrinolytic agent, has gained increasing attention due to its anti‐inflammatory and antimelanogenic properties.
Ahmed AlJabr +2 more
wiley +1 more source
Intraovarian Platelet-Rich Plasma Therapy for PCOS: Unanswered Questions and Future Research Directions. [PDF]
Merhi Z.
europepmc +1 more source
ABSTRACT Preserved allocyclic signatures in the rock record often reflect basin‐scale climatic variability and serve as key proxies for correlating ancient dryland successions. The notion of climate cyclicity, however, remains largely untested on regionally constrained, outcrop‐calibrated studies.
Oliver Button +4 more
wiley +1 more source
Best evidence summary for platelet-rich plasma treatment of chronic wounds. [PDF]
Zhang X +9 more
europepmc +1 more source
Receptor‐Dependent and ‐Independent Effects of Hemin on Platelet Plasma Membrane Disintegration
Microhemorrhages lead to the release of erythrocytes, which are then degraded and lysed. These hemolyses result in the liberation of free iron‐containing hemin. Hemin induces platelet activation and ferroptosis. Inhibition of GPVI/CLEC‐2 receptor‐mediated ITAM‐signaling inhibits hemin‐induced platelet activation (low hemin concentrations). Deferoxamine,
Zoi Laspa +5 more
wiley +1 more source
Treatment using either the thiol isomerase inhibitor isoquercetin or zafirlukast lowers tissue factor levels, decreases VEGF, inhibits PD‐L1, and TMEM176B in a xenograft model of ovarian cancer. A combination of the two agents, at threefold lower concentrations than either drug, significantly enhanced the inhibition further, suggesting a dual action of
Justine A. Keovilay +4 more
wiley +1 more source
Comparative analysis of liquid and gel platelet rich plasma from apheresis and buffy coat in wound healing. [PDF]
Marraccini C +11 more
europepmc +1 more source

